Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
A Northwest Biotherapeutics Inc. investor sued members of its board in Delaware
I hope the investor will win they have a good point it does not concern Northwest so i dont care really
It would not surprise me if we see 1 cent up and 1 cent down until news
ok thanks
didnt know that obviously Im not from Delaware
wait a minute you are saying NWBO's 2019 10K has never been approved by an ASM...? That would be illegal.
interesting didn't know, thanks
that is correct I was just wondering according to Delaware law. If a listed company exists 24 years can it then after 24 months thus 2 years hold its ASM over 2020 somewhere in 2022? I mean 13 months after the last ASM would postpone the ASM every year with 1 month after the year before legally
anyone?
exactly its absurd
funny the longer the company waits to publish the article the more cancer-related relevant medical news appears, triggering the company/the authors to respond to this news in the article which increased the wait and thus increases the chance for new cancer-related relevant medical cancer news to appear and so on and so on
Its a beautiful never ending cycle.
If the invention of antibiotics had waited in this manner we would still be waiting for the Journal of Medicine
Ooh Les is not lying when financiers ask what the present situation of the company is in order to be able to make a balanced and informed decision to yes/no invest in the company, no he is just fantasizing about ideas? The little rascal lol
you call it panicking we call it a request for accountability.
But what do I know I have only been an investor in multi start-ups since 2005
yes, I know.
but it's still no excuse for their incredibly poor communication skills.
thank you senti.
Lets hope this delay is the last one
I agree with you. What happened is that management has themselves painted in a corner by chaining the journal publication to the disclosure of topline data. Now that the journal has encountered substantial delays the paint just won't dry so they cant step out of that locked room anymore. Had they followed the route that normal functioning biotechs do: disclosing topline data with the promise of a journal publication in the future then BLA submission/request RA approval then the news of approval (or not) we would not be in this sh*t forsaking awful mess.
I have no idea why the publication has been delayed and what the obstacles delaying the publication are but in my view, it's material information at this point, and they should disclose the reasons for the delay.
I have said and will say again that they are FAR IN the process OF getting MHRA approval. You are a master twisting my words. You can not make such guarantees because you have zero clue as always.
I hear you. I’m not a fan of the way they have handled things and I will sell after MHRA good news.
I can’t disagree. On the other hand I would be thrilled with good news from the MHRA and then they can stick the article for all I care…
Meirluc there is a lot of talking between Les and bigger financiers. That’s a fact. Much what he (Les) said then later turned out not come to pass. ( much to the annoying of those that receive that info from him)
IMO Les loves to talk when the company needs finances… IMO
PM again and I can’t stress this enough I never said they can not, are not able to. I said it’s taken TOO long which they now recognize as wel. I agree that whatever is holding the publication up is something that is worrisome.
I think we will eventually see a / the publication after the obstacles have been overcome. When….?? Dunno
Thats your prerogative its a free country
Welcome
I agree but I do believe they decided to disclose TLD with MHRA approval.
That would good news yes. The market would appreciate approval above the scientific publication
PM I have come to the conclusion, and I have some pretty solid indications to think that the journal publication has encountered some tough and difficult obstacles. They, therefore, decided to go for RA approval and let the publication sit it out, could come soon, may take many months still.
Best hope for us now is MHRA approval. I believe they are very close in that process. I have information that IF the MHRA would have dismissed the request of getting approval they would have had to stop producing DCVAXL in the UK altogether.
It would therefore not surprise me one bit if we see the next PR of MHRA approval + topline data ex thus without journal publication in the next 2-4 months.
here is the problem with that Senti. In the past, Les has lied a great deal to get capital. I happen to know that for a fact and you know that too.
lol ooh yes today is that day
agree
right now Im more than happy if the data would appear in a Disney magazine ;)
but why cant we make the difference between revealing how the trial did and submitting a request for approval? NWBO could have disclosed the hell out of the data without being able to produce one vaccine. I dont understand this premise being made here.
you are diverting from the subject. these over and over repeated mantras of praise wont do it for me nor have they anything to do what was discussed.
I disagree with you Dr Bala.
First of all, there are quite a few options for GBM patients to get unproven treatment so what you said is simply not true. Heck if within a medical trial then, if accepted as a trial patient, the treatment for free and the patient does not need to sell his/her home.
Second
In my view as I have said before its of unprecedented cruelty to have patients pay what his her last $200k for a treatment in a life-threatening situation while F sitting on data knowing it works yes or no. For the life of me, I can't comprehend that one. And no if there is no data then the patient's MD will not recommend getting DCVAXL. It's outrageous.